Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The Department of Drug Administration (DDA) in Nepal is formulating good manufacturing practice (GMP) regulations to maintain and meet the specification of pharmaceutical companies defined by the World Health Organisation (WHO).
Subscribe to our email newsletter
The DDA has invited all drug companies to register under WHO-GMP within mid-April 2012, The Himalayan Times reported.
With the introduction of the norms, it will be obligatory for the drug manufacturers to maintain and meet certain conditions such as similar procedures and conditions.
DDA director Radha Prasad said the department is drafting the regulations to upgrade the standard of Nepali pharmaceutical companies to attain international recognition.